End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
38.43 CNY | +0.26% | -0.93% | -19.94% |
05-20 | US Legislation Banning Chinese Biotech Firms Will Suppress Legislation, BGI Says | MT |
04-26 | BGI Genomics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2022 | 7.05B 974M 1.33B | Sales 2023 | 4.35B 601M 822M | Capitalization | 19.68B 2.72B 3.72B |
---|---|---|---|---|---|
Net income 2022 | 803M 111M 152M | Net income 2023 | 92M 12.71M 17.4M | EV / Sales 2022 | 2.13 x |
Net cash position 2022 | 6.21B 858M 1.17B | Net cash position 2023 | 5.12B 708M 968M | EV / Sales 2023 | 3.35 x |
P/E ratio 2022 |
26.4
x | P/E ratio 2023 |
213
x | Employees | - |
Yield 2022 |
1.93% | Yield 2023 |
0.21% | Free-Float | 52.17% |
1 day | +0.26% | ||
1 week | -0.93% | ||
Current month | -2.11% | ||
1 month | -9.89% | ||
3 months | -11.12% | ||
6 months | -24.42% | ||
Current year | -19.94% |
Managers | Title | Age | Since |
---|---|---|---|
Li Jian Zhao
CEO | Chief Executive Officer | - | 21-06-15 |
Jian Hua Wang
FOU | Founder | 70 | - |
Yu Jue Wang
DFI | Director of Finance/CFO | 46 | 21-06-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jian Hua Wang
FOU | Founder | 70 | - |
Hong Tao Wang
BRD | Director/Board Member | - | 16-03-28 |
Ye Yin
BRD | Director/Board Member | 45 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-11 | 38.43 | +0.26% | 1 755 696 |
24-06-11 | 38.33 | +1.97% | 1,542,771 |
24-06-07 | 37.59 | -0.79% | 1,612,075 |
24-06-06 | 37.89 | -1.92% | 2,517,948 |
24-06-05 | 38.63 | -0.41% | 1,827,005 |
End-of-day quote Shenzhen S.E., June 11, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.94% | 2.01B | |
+18.08% | 3.73B | |
+8.30% | 2.41B | |
-18.79% | 1.63B | |
+20.53% | 1.08B | |
+30.92% | 776M | |
-9.83% | 679M | |
-26.53% | 508M | |
-6.96% | 291M | |
-15.37% | 162M |
- Stock Market
- Equities
- 300676 Stock